{
    "Trade/Device Name(s)": [
        "Access Total \u03b2hCG (5th IS) Assay",
        "Access Total \u03b2hCG (5th IS) Calibrators"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K130020",
    "Predicate Device Reference 510(k) Number(s)": [
        "K925277"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DHA",
        "J1X"
    ],
    "Summary Letter Date": "October 1, 2013",
    "Summary Letter Received Date": "September 18, 2013",
    "Submission Date": "September 17, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1155",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Human chorionic gonadotropin (HCG) test system",
        "Secondary Calibrator"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Total \u03b2hCG (intact hCG and free beta-subunit)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Access Immunoassay Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Paramagnetic particle assay",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Automated immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Access Total \u03b2hCG (5th IS) assay and calibrators for quantitative determination of \u03b2hCG in human serum and plasma using Access Immunoassay Systems.",
    "Indications for Use Summary": "Aid in early detection of pregnancy by quantitatively determining total \u03b2hCG levels in human serum and plasma using the Access Immunoassay Systems.",
    "fda_folder": "Clinical Chemistry"
}